Short answer
Quest Diagnostics (DGX) filed an 8-K current report with the SEC on October 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter 2026 results for period ended September 30, 2026.
Quest Diagnostics 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter 2026 results for period ended September 30, 2026
- Press release issued October 22, 2026
- Exhibit 99.1 contains financial results and management commentary
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $3.097B, up 10.0%, with requisition volume up 14.5% offset by revenue per requisition down 4.2%
- Reported diluted EPS $2.78, up 28.7%; adjusted EPS $3.00, up 15.4%, signaling strong operating leverage
- Operating margin expanded to 15.5% from 13.7%; adjusted margin reached 16.7%
- 2026 guidance raised: revenue $12.065B-$12.105B and adjusted EPS $11.25-$11.35
- Cash-from-operations guidance increased to approximately $1.90B, supporting investment and shareholder returns
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quest Diagnostics 8-K filings
Get the next DGX 8-K as it lands
Follow DGX for push alerts, or ask the research agent what this filing means.